122 related articles for article (PubMed ID: 14726189)
1. Expiry-date tampering.
Day JN; Hien TT; Farrar J
Lancet; 2004 Jan; 363(9403):172. PubMed ID: 14726189
[No Abstract] [Full Text] [Related]
2. Expiry-date tampering.
Watt G
Lancet; 2004 Jan; 363(9403):172. PubMed ID: 14726190
[No Abstract] [Full Text] [Related]
3. Counterfeit and substandard drugs in India may be smaller problem than claimed, say government findings.
Travasso C
BMJ; 2014 Jan; 348():g60. PubMed ID: 25489932
[No Abstract] [Full Text] [Related]
4. The IVD directive: late-phase practicalities.
Johnson P; Walker R
Med Device Technol; 2003 Nov; 14(9):35-6. PubMed ID: 14682022
[No Abstract] [Full Text] [Related]
5. Notes on equipment/supplies.
Dumas T; Gile TJ
MLO Med Lab Obs; 2008 Oct; 40(10):34. PubMed ID: 18988554
[No Abstract] [Full Text] [Related]
6. Labelling deficiencies in test kits for the detection of antibodies to rubella.
Katz L; Hinberg IH; Weber F
Clin Biochem; 1979 Aug; 12(4):146. PubMed ID: 487565
[No Abstract] [Full Text] [Related]
7. Coping with the IVD directive.
Gower G
Med Device Technol; 2000 Oct; 11(8):28-9. PubMed ID: 11185185
[TBL] [Abstract][Full Text] [Related]
8. I understand the Food and Drug Administration doesn't regulate dietary supplements as it does prescription drugs. What do I look for when shopping for vitamins and supplements?
Mayo Clin Health Lett; 2010 Dec; 28(12):8. PubMed ID: 21229659
[No Abstract] [Full Text] [Related]
9. Are there fakes and frauds in your nebulizer?
Allergy & Asthma Network Mothers of Asthmatics
School Nurse News; 2005 Mar; 22(2):15-7. PubMed ID: 15875950
[TBL] [Abstract][Full Text] [Related]
10. Counterfeiting and piracy of pharmaceuticals.
Grackin A
IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
[No Abstract] [Full Text] [Related]
11. Revised recommendation (1983) on evaluation of diagnostic kits. Part 1. Recommendations for specifications on labelling of clinical laboratory materials. International Federation of Clinical Chemistry.
Logan JE
Clin Chim Acta; 1984 Mar; 137(3):371F-379F. PubMed ID: 6697538
[No Abstract] [Full Text] [Related]
12. Indian generics manufacturer Ranbaxy agrees to pay $500m to settle US fraud and drug safety charges.
Kay M
BMJ; 2013 May; 346():f3536. PubMed ID: 23723460
[No Abstract] [Full Text] [Related]
13. Label fables: EPA cites hype in 'bugproof' products.
Blyth PL
Health Facil Manage; 1998 Sep; 11(9):54, 56-7. PubMed ID: 10182769
[No Abstract] [Full Text] [Related]
14. European GMO labeling thresholds impractical and unscientific.
Weighardt F
Nat Biotechnol; 2006 Jan; 24(1):23-5. PubMed ID: 16404384
[No Abstract] [Full Text] [Related]
15. Helping your patients avoid counterfeit medicines.
Teichman PG
Fam Pract Manag; 2007 Mar; 14(3):33-5. PubMed ID: 17408128
[No Abstract] [Full Text] [Related]
16. Prohibited acts and enforcement tools.
Mathewson NW
Food Drug Law J; 2010; 65(3):545-54. PubMed ID: 24479241
[No Abstract] [Full Text] [Related]
17. Angelic doctors.
Mani MK
Natl Med J India; 2011; 24(2):113-4. PubMed ID: 21668058
[No Abstract] [Full Text] [Related]
18. Assessment of package inserts for diagnostic kits.
Secchiero S; Sciacovelli L; Bonvicini P; Zaninotto M; Plebani M
Clin Chem Lab Med; 1999 Jun; 37(6):663-5. PubMed ID: 10475075
[TBL] [Abstract][Full Text] [Related]
19. Model for tuning GMO detection in seed and grain.
Macarthur R; Murray AW; Allnutt TR; Deppe C; Hird HJ; Kerins GM; Blackburn J; Brown J; Stones R; Hugo S
Nat Biotechnol; 2007 Feb; 25(2):169-70. PubMed ID: 17287745
[No Abstract] [Full Text] [Related]
20. Does customer information fulfill MEDDEV criteria in cases of product problems of in vitro diagnostics for infection testing?
Hannig J; Siekmeier R
Adv Exp Med Biol; 2015; 835():23-30. PubMed ID: 25310946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
